Fed. Circ. Vacates PTAB Ax Of Guardant DNA Test Patent
The Federal Circuit on Friday rolled back a decision by the Patent Trial and Appeal Board that wiped out nearly all challenged claims in a Guardant Health patent on DNA testing...To view the full article, register now.
Already a subscriber? Click here to view full article